MELBOURNE, Australia, Jan 6 (Bernama) -- Gordagen Pharmaceuticals, an
Australian company developing evidence-based nutraceuticals and
pharmaceuticals, today announced it has entered into a Collaborative
Product Development Agreement with long-standing Japanese company
Matsumoto Trading Co, Ltd.
The Agreement covers the development of a new functional food product
for the Japanese market, which will incorporate Gordagen's proprietary
and patented MELT3(TM) tocotrienol delivery technology.
http://www.bernama.com/bernama/v8/newsindex.php?id=1204571
No comments:
Post a Comment